Join to View Full Profile
561 Saxony PlSuite 102Encinitas, CA 92024
Phone+1 760-203-3839
Fax+1 760-203-3840
Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Naval Medical Center (San Diego)Residency, Dermatology, 1990 - 1993- Naval Medical Center (San Diego)Internship, Transitional Year, 1986 - 1987
Drexel University College of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1989 - 2026
FL State Medical License 2022 - 2024
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- Deoxycholic Acid Injection for the Treatment of Superficial Lipomas Start of enrollment: 2007 Jan 01
- A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis Start of enrollment: 2013 Nov 01
- DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Randomized Phase IIa Trial of Purified Candida Antigen for Common Warts: Evaluating the Safety and Efficacy Across Multiple Dosing Regimens.Stacy R Smith, Robert E Esch, H S Nielsen, Sandra Marchese Johnson
Dermatology and Therapy. 2025-03-29 - Sofpironium topical gel, 12.45%, for the treatment of axillary hyperhidrosis: Pooled efficacy and safety results from 2 phase 3 randomized, controlled, double-blind st...David Pariser, Dee Anna Glaser, James Del Rosso, Neal Bhatia, Deirdre Hooper
Journal of the American Academy of Dermatology. 2025-03-05 - A Phase 1, Open-Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6-12 Years With Alopecia Areata.Mercedes E Gonzalez, John Browning, Stacy Smith, Anna Plotka, Jing Daisy Zhu
Pediatric Dermatology. 2025-02-09
Press Mentions
Topical Anticholinergic for Axillary Hyperhidrosis Shows Fewer Side EffectsApril 25th, 2021
Sofpironium Bromide Demonstrates Promising Potential as a Safe and Effective First-Line Treatment for Primary Axillary Hyperhidrosis (Excessive Underarm Sweating)February 20th, 2018
How Much Should You Really Sweat During a Workout?September 25th, 2017
Professional Memberships
- Fellow
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
